DRUG GUIDELINE

Dexmedetomidine
SCOPE (Area): ICU, Theatre, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), (Exclude: Coronary Care Unit)
SCOPE (Staff): Clinical Staff
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Areas outside ICU and Theatre. Paediatrics (seek Paediatrician advice).


Preamble

See Appendix 1 for full version of this Drug Guideline!


Related Documents

CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0549 - High Risk Medications
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
CPG0208 - Delirium management of adult patients in the Intensive Care Unit
SOP0001 - Principles Of Clinical Care


References

Alfred Health (2020, March). Dexmedetomidine Drug Guideline. Alfred Health. Retrieved March 28, 2023 from
Barwon Health (2018, October). Dexmedetomidine Drug Protocol. Barwon Health. Retrieved March 28, 2023 from
Bendigo Health (2022, April). Dexmedetomidine (Precedex) Drug Protocol. Bendigo Health. Retrieved March 28, 2023 from
CRC Press, Taylor and Francis Group (2023). The Renal Drug Database. Retrieved March 29, 2023, from
Credible Meds. (2023). QTDrugs List. Retrieved March 29, 2023 from
MIMS Australia. (2023). MIMS Online, Dexmedetomidine product information. Retrieved March 29, 2023 from
Peninsula Health (2022, October). Dexmedetomidine Adult Drug Administration Guideline. Peninsula Health. Retrieved March 28, 2023 from
Rossi, S. (2023, January). Australian Medicines Handbook. Retrieved March 29, 2023 from https://amhonline.amh.net.au.acs.hcn.com.au/?acc=36265.
Royal Melbourne Hospital (2020, October). DEPARTMENT OF ANAESTHESIA AND PAIN MEDICATION GUIDELINE Dexmedetomidine. Royal Melbourne Hospital. Retrieved March 28, 2023 from
Royal Melbourne Hospital (2021, November). INTENSIVE CARE UNIT MEDICATION GUIDELINE Dexmedetomidine. Royal Melbourne Hospital. Retrieved March 28, 2023 from
The Society of Hospital Pharmacists of Australia. 2023. Australian Injectable Drugs Handbook (8th ed.). Retrieved March 29, 2023 from
Therapeutic Guidelines Limited. (2023, March). Cardiovascular Guidelines. Retrieved March 29, 2023 from
UpToDate, Inc. (2023) UpToDate (including drug interactions). Retrieved March 29, 2023, from


Appendix

Appendix 1 - Dexmedetomidine



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 11/07/2023
Review Responsibility: Pharmacist - Rotational Date for Review: 11/07/2026
Dexmedetomidine - DRG0056 - Version: 5 - (Generated On: 24-05-2025 05:54)